Management of secondary postpartum haemorrhage: A systematic review
- PMID: 36708658
- DOI: 10.1016/j.ejogrb.2023.01.023
Management of secondary postpartum haemorrhage: A systematic review
Abstract
Secondary postpartum haemorrhage is a significant cause of postnatal morbidity and admission to hospital. It can be managed medically, surgically or with interventional radiological techniques, however, there is limited evidence to inform the most appropriate use of these treatments. This review aimed to summarise the existing evidence and evaluate the effectiveness and safety of the management options available for secondary postpartum haemorrhage. MEDLINE, EMBASE, CENTRAL, SCOPUS, Clinicaltrials.gov and ICTRP were searched from conception to August 2021. Eligible studies described the management of participants with secondary postpartum haemorrhage occurring between 24 h and 12 weeks after a pregnancy of at least 20 weeks gestation. All treatment interventions were eligible. Outcomes included reduction of bleeding, hospital admissions, re-presentations to hospital, secondary surgical procedures, blood transfusions, adverse effects of treatment, surgical complications, hysterectomy, ICU admissions, severe morbidity and mortality. The protocol for this review was registered with PROSPERO (ID: CRD42021274146). Eleven studies, describing 834 participants, were eligible for inclusion. Five studies reported outcomes of a single intervention and six studies reported outcomes of more than one treatment modality. Assessed interventions included medical management, surgical procedures, and radiological techniques. Resolution of bleeding was seen in 8.2-84.6 % of participants following medical management, 89.3-100 % following surgical management and 87.5-100 % post transcatheter arterial embolisation. When considering only studies published in the last 30 years, these results are 71.9-73.7 %, 89.3-92.0 % and 87.5-100 % respectively. All included studies were small and retrospective observational in design with poor methodological quality leading to a serious or critical risk of bias. This review has highlighted the deficiencies in evidence for the management of secondary PPH. Future, well designed, prospective studies are needed to provide guidance to clinicians managing this condition.
Keywords: Endometritis; Puerperal disorders; Retained products of conception; Secondary postpartum hemorrhage.
Copyright © 2023 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis.Cochrane Database Syst Rev. 2018 Apr 25;4(4):CD011689. doi: 10.1002/14651858.CD011689.pub2. Cochrane Database Syst Rev. 2018. Update in: Cochrane Database Syst Rev. 2018 Dec 19;12:CD011689. doi: 10.1002/14651858.CD011689.pub3. PMID: 29693726 Free PMC article. Updated.
-
Oxytocin for preventing postpartum haemorrhage (PPH) in non-facility birth settings.Cochrane Database Syst Rev. 2016 Apr 14;4(4):CD011491. doi: 10.1002/14651858.CD011491.pub2. Cochrane Database Syst Rev. 2016. PMID: 27078125 Free PMC article.
-
Methods for blood loss estimation after vaginal birth.Cochrane Database Syst Rev. 2018 Sep 13;9(9):CD010980. doi: 10.1002/14651858.CD010980.pub2. Cochrane Database Syst Rev. 2018. PMID: 30211952 Free PMC article.
-
Methods for managing miscarriage: a network meta-analysis.Cochrane Database Syst Rev. 2021 Jun 1;6(6):CD012602. doi: 10.1002/14651858.CD012602.pub2. Cochrane Database Syst Rev. 2021. PMID: 34061352 Free PMC article.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
Cited by
-
Embolization with gelatin foam in the management of vascularized retained products of conception: a multicenter study by the French Society of Cardiovascular Imaging.Eur Radiol. 2025 May;35(5):2499-2507. doi: 10.1007/s00330-024-11199-0. Epub 2024 Nov 19. Eur Radiol. 2025. PMID: 39562364
-
Gestational choriocarcinoma FIGO stage III, score 8 (high-risk) in 38-year-old woman four weeks postpartum.Case Rep Perinat Med. 2025 Jun 12;14(1):20240041. doi: 10.1515/crpm-2024-0041. eCollection 2025 Jan. Case Rep Perinat Med. 2025. PMID: 40520651 Free PMC article.
-
Uterus-Preserving Management of Intractable Haemorrhage Following Suction and Evacuation: A Case Series.Cureus. 2025 Apr 2;17(4):e81606. doi: 10.7759/cureus.81606. eCollection 2025 Apr. Cureus. 2025. PMID: 40322397 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources